NCT05643001

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 340 (actual)
• Sponsor: Massachusetts General Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The overall goal of this study is to increase health care provider awareness for common risk factors and comorbidities in patients with hemorrhagic stroke that are related to impaired brain health, to ultimately improve patients management and associated outcomes. The specific objective is to test the performance and effectiveness of a custom electronic health record (EHR)-based notification module at time of index hospitalization and at follow-up for hemorrhagic stroke survivors, before disparities in access to outpatient care may limit opportunities to intervene. The investigators hypothesize that notification of health care providers through the EHR will increase measurements of low-density lipoprotein (LDL) and glycated hemoglogbin A1c (HbA1c) and increase evaluation and management rates for obstructive sleep apnea and hearing impairment.

Conditions

• Hemorrhagic Stroke

Interventions

Type	Name	Description
OTHER	In-patient and out-patient electronic health record alert	Electronic health record best practice alert which suggests measurement of LDL and HbA1c (in-patient) and referrals to sleep study and audiology (out-patient)

Timeline

• Start date: 2023-03-15
• Primary completion: 2024-04-18
• Completion: 2025-03-28
• First posted: 2022-12-08
• Last updated: 2025-05-08

Locations

1 site across 1 country: United States